‹ All stocks

Neuphoria Therapeutics

NEUP · NASDAQ · Healthcare

$3.45

▲ $3.45 (0.29%)

1D 7D 1M 3M 1Y All

Day range

$3.44 – $3.54

Year range

$3.19 – $21.40

Open

$3.44

Previous close

—

Market cap

$18.65M

Volume (24h)

$808

Volume (52w)

$2.79K

Performance

▼ -5.48%

▼ -8.00%

▼ -3.90%

▼ -26.60%

▼ -82.75%

YTD

▼ -9.69%

▼ -92.81%

▼ -98.05%

All-time

▼ -98.05%

Key statistics

P/E ratio

-1.74

EPS (TTM)

$-1.98

Dividend yield

—

Dividend (TTM)

—

Payout ratio

—

Shares outstanding

5.4M

About Neuphoria Therapeutics

Neuphoria Therapeutics, Inc. is a biotechnology company currently advancing treatments through clinical trials. Its core mission involves pioneering therapies specifically engineered to address the intricate requirements of individuals living with neuropsychiatric disorders. The company was established on December 23, 2024, and its main corporate offices are located in Burlington, Massachusetts.

Visit website

Country: United States of America

LLY Eli Lilly and Company	$1143.12	-0.59%
JNJ Johnson & Johnson	$252.93	-2.22%
ABBV AbbVie	$265.76	2.20%
MRK Merck & Co.	$139.54	-2.97%
UNH UnitedHealth Group Incorp…	$378.58	3.66%